Doctors in India have been warned to refrain from attending events sponsored by companies that violate the Infant Milk Substitutes (IMS) Act. The IMS Act aims to regulate the marketing of baby food and protect breastfeeding. The call to shun these meetings was made by the Indian Academy of Pediatrics (IAP) during their annual conference. The IAP emphasized the importance of upholding ethical standards and urged doctors to prioritize the well-being of infants over any financial incentives offered by companies that breach the IMS Act. The move comes as a response to concerns about the aggressive marketing tactics employed by some companies to promote infant milk substitutes, which can have negative effects on breastfeeding rates and infant health. By boycotting events hosted by these companies, doctors can help uphold the IMS Act and promote breastfeeding as the optimal feeding choice for infants. The IAP’s stance underscores the importance of ethical medical practices and the need to prioritize the health and well-being of patients above all else. This call to action is a significant step towards ensuring compliance with regulations aimed at safeguarding infant health in India.